THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY
Despite large number of known risk factors of venous thromboembolism (VTE) in cancer patients existing prediction models do not allow definite identification of cancer patients that have indications for anticoagulant prevention. Besides, heparin and warfarin use for VTE prevention in cancer is accom...
Saved in:
Main Authors: | A. A. Rumyantsev (Author), I. A. Pokataev (Author), T. V. Kozlov (Author), N. A. Rumyantsev (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY
by: A. A. Rumyantsev, et al.
Published: (2015) -
Efficient sequence of therapy for advanced and metastatic endometrial cancer
by: A. A. Rumyantsev
Published: (2022) -
Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants
by: Ju Yup Lee
Published: (2018) -
Hepatotoxicity of New Oral Anticoagulants
by: A. R. Kasimova, et al.
Published: (2018) -
Safety of ECT in patients receiving an oral anticoagulant
by: Nicolette R. Centanni, PharmD, BCPS, BCGP, BCPP, et al.
Published: (2021)